Maturation-promoting factor (MPF) is a cell cycle control element able to cause metaphase when injected into amphibian oocytes or when incubated with nuclei in a cell-free system. Highly purified MPF consists of a complex between a 34K (K = 10 3Mr) serine/threonine protein kinase, identified as aXenopus homolog of the cdc2+ gene product, p34J* 2, and a 45K substrate, identified as a Xenopus B-type cyclin. p34cdc2 is also present in purified preparations of chromatin-derived growth-associated histone HI kinase from Novikoff hepatoma cells. p34cdc2 is active when dephosphorylated and inactive when phosphorylated during oocyte meiotic cell cycles and in mitotic cell cycles following egg activation. Analysis of the substrate specificity of p34cdcZ indicates a consensus sequence for phosphorylation of (K/r )S/tP (X )K /r . Among substrates identified with this consensus are histone HI and the pp60csrc proto-oncogene, which is known to be activated and phophorylated in mitosis. MPF injection into oocytes activates ribosomal protein S6 kinase II, which is also a lamin kinase. The mechanism of activation is indirect, possibly involving the c-src proto-oncogene. Continued analysis of regulation of MPF activation/inactivation and characterization of substrates for phosphorylation will have important implications for cell cycle and cell growth control.
Introduction
Recently there has been remarkable progress in our understanding of the animal cell cycle as evidenced by the exciting developments presented at this meeting. This is partly a consequence of convergence of cell cycle control elements into a system that combines biochemistry and genetics in the study of the cell cycle. In this brief article, we will review the recent developments from our work that contribute to this new picture.
Two cell cycle control elements have been well documented in the past. One of these is maturation-promoting factor (MPF) and the other is the cdc2+ gene. MPF was first described nearly 18 years ago as an activity present in metaphase cytoplasm of maturing oocytes and unfertilized eggs that could cause immature oocytes to undergo oocyte maturation, a G 2 -»M transition (Masui & Markert, 1971 ; Smith &
Development of a cell-free system for early mitotic events
In 1983, Lohka & Masui reported the development of a cell-free system from unfertilized R ana eggs that could induce early mitotic events in nuclei, including nuclear envelope breakdown and chromosome condensation. However, if extracts were made in the presence of calcium, DN A synthesis was induced (Lohka & Masui, 1983 , 1984 . This difference in inducing activity of the cell-free extracts is similar to the difference in cell cycle state of eggs before and after fertilization, an event induced by calcium ions. The development of the cell-free system is having a profound effect on the biochemical and molecular analysis of the cell cycle as well as on many fundamental processes such as DN A replication, chromosome conden sation, nuclear assembly/disassembly, and spindle formation. For example, Laskey and his colleagues have used the egg extracts to develop the first eukaryotic DN A replication system in vitro (Blow & Laskey, 1986) . Lohka & Mailer (1985) adapted this system to Xenopus eggs and showed that MPF partially purified by the oocyte injection assay was able to cause nuclear breakdown and chromosome condensation in vitro. Significantly, the assay was able to detect intermediate levels of activity, with a unit of M PF defined as that amount which caused at least 20 % of nuclei in a field to break down. The control of the cell cycle by protein phosphorylation with M PF that had been inferred from oocyte injection experiments appeared to be retained in the cell-free system because MPF action was inhibited by App(NH)p, a nonhydrolyzable analog of ATP unable to be utilized by protein kinases (Lohka & Mailer, 1985) . Direct analysis by two-dimensional gel electrophoresis showed that the same set of six proteins became selectively phosphorylated in M phase in the cell-free extract and in vivo (Lohka et al. 1987) . Although these six proteins are probably important in the control of the cell cycle, none has been identified as yet. A ll of these proteins contain both phosphoserine and phosphothreonine in M phase and one, a 4 2K (K = 1 0 3M r) protein, also contains phosphotyrosine (Lohka et al. 1987 ).
Purification of MPF
The cell-free system offered a new assay for MPF that eliminated many of the disadvantages of the oocyte microinjection assay. Lohka et al. (1988) devoted a substantial effort to purifying MPF, using nuclear envelope breakdown (NEBD) in vitro as the assay. The purification required the inclusion of ATPyS during extraction and the presence of /3-glycerophosphate during extraction and assay. Both of these unusual buffer components were necessary for success, but even so, MPF activity was highly unstable and it was necessary to start with kilogram quantities of eggs and to use batch chromatographic procedures early in the purification to reduce losses of MPF activity. In the end, however, we succeeded in purifying M PF 3500-fold to near homogeneity; it consisted of two proteins of 34K and 45K . It was active in causing NEBD in the cell-free system as well as GVBD in less than 2 h in oocytes treated with cycloheximide. The original hypothesis that M PF might express a protein kinase activity was confirmed with the demonstration that the 45 K component became phosphorylated by the 34K component upon incubation with MgATP, and the purified MPF also expressed kinase activity against exogenous histone HI, M AP-2, phosphatase inhibitor-1 and a-casein (Lohka et al. 1988).
MPF and p34c£#c2
An important question concerned whether MPF might be related to any other known cell cycle components. This was of particular interest because genetic work in the fission yeast Schizosaccharomyces pombe had established that the product of the cdc2+ gene was a central regulator of the G 2 ->M transition (Nurse, 1985 
Regulation of MPF activity
The activity of many protein kinases is regulated by association with other components. Several groups have studied components associated with p34cdc2 during the cell cycle. The approach has been to identify proteins that co-immunoprecipitate writh p34cdc2 or that co-purify with functionally-active p34cdc2. In HeLa cells, Draetta & Beach ( The function of these associated components at present is unknown. Most if not all protein kinases consist of regulatory and catalytic subunits or domains, so it is tempting to speculate that the components associated with p34cdc2 represent regulatory elements. Ironically, in the fission yeast S. pombe, analysis indicates that p3 4 "^2 does not form a high molecular weight complex during any point in the cell cycle (Simanis and Nurse, 1986); however, when subjected to nutritional depri vation, p34cdc2 becomes dephosphorylated, suggesting the potential for regulation by phosphorylation. This idea is further supported by analysis of the wee 1 + gene. Mutations in wee 1 + lead to early entry into mitosis, indicating wee 1 + exerts a negative regulation of the cdc2+ gene (Russell & Nurse, 1987a) and sequence analysis of the wee 1 + gene reveals a protein predicted to be 11 OK containing the consensus sequence for serine/threonine protein kinases. These observations suggest the potential for both stimulatory and inhibitory phosphorylation of p34cdc2.
Regulation of MPF kinase by phosphorylation
Because of the potential regulation of p34cdc2 by phosphorylation, we have investigated its phosphorylation state in vivo during the cell cycle in relation to the level of protein kinase activity. Measurement of HI kinase activity during oocyte maturation and after fertilization revealed a 10-fold increase in interphase that was reversed as the cell entered M phase (Gautier et al. 1989 ). Analysis of the sites in HI phosphorylated when the increase occurs indicates only growth-associated kinase sites are labelled (Gautier, Langan and Mailer, unpublished), suggesting that all of the increase can be accounted for by p34cdc2. Western blotting with the PSTA IR antibody during the oscillation revealed no important change in the amount of p34cdc2, indicating activation/deactivation is the underlying mechanism. The phosphorylation state of p34cdc2 was monitored by microinjection of [y-32P] ATP into oocytes followed by immunoprécipitation and S D S -P A G E . When HI kinase activity was high, little or no 32Pi was present in p34dcd2, but when the kinase activity decreased during the cell cycle, the kinase becomes phosphorylated (Gautier et al. 1989). Immune complex kinase assays confirmed these changes in lysate kinase activity were due to p34cdc2. The detection of these biochemical changes in p34cdc2 are consistent with the hypothesis that a pathway exists for negative regulation by phosphorylation of cdc2+, possibly via the product of the w e e l+ gene. For total confirmation, this hypothesis requires isolation of the kinases and phosphatases that act on p34cdc2.
Recently Beach and collaborators reported that immunoprécipitation of p34cdc2 from mitotic HeLa cells showed the presence of both phosphothreonine and phosphotyrosine (Draetta et a l. 1988) . Moreover, incubation of partially-purified kinase-negative p3 4 «fc2 w jtj1 pp60v'src resulted in in vitro phosphorylation of p34cdc2 on tyrosine residues. Peptide mapping of p34cdc2 demonstrated that a peptide phosphorylated in vitro co-migrated with one of the in vivo phosphopeptides (Draetta et al. 1988) . These results are potentially exciting, particularly since pp60c'src is known to be active in mitosis, most likely due to increased phosphorylation in the amino terminus of c-src at mitosis (Chackalaparampil and Shalloway, 1988). However, it is not clear if phosphotyrosyl p34cdc2 immunoprecipitated from HeLa cells is part of either MPF or the fraction present as a high molecular weight complex (Draetta and Beach, 1988). In addition, it has not yet been demonstrated that the phosphorylation is at a significant stoichiometry in vivo or in vitro, nor is there any evidence that tyrosine phosphorylation affects the function of p34cdc2. Since denatured proteins are markedly better substrates for pp60v'src it will be important to determine if native p34cdc2 can also be a substrate for pp60°'src. . 1980 ). In the last few years two laboratories have partially purified, from mitotic mammalian cell chromatin, the protein kinase that specifically phosphorylates these sites in mitotic HI histone. This enzyme, termed the growthassociated kinase, consists of a complex of a 62K and a 34K protein (Chambers and Langan, unpublished). Immunoblotting of partially-purified rat growth-associated kinase with the PSTA IR antibody revealed that the 34K component was a mammalian homolog of cdc2+ (Langan et al. 1989). Since p34cdc2 is the catalytic subunit of several different complexes, it can be predicted that these should all phosphorylate the growth-associated sites in HI and both MPF and growthassociated kinase immunoprecipitated by the PST A IR antibody are able to phos phorylate these sites; even yeast extracts contain kinase activity for these sites (Langan et al. 1989) . Significantly, yeast defective in the cdc2 or CDC28 genes was specifically unable to phosphorylate these sites, providing genetic evidence that p34cdc2 is, in fact, the catalytic subunit of growth-associated kinase (Langan et al. Recently we have been investigating the possibility that M PF might activate pp60c-src. This was an attractive possibility, because pp60c-src is activated 4-7-fold at mitosis by serine and threonine phosphorylation in the amino terminal region of the protein (Chackalaparampil and Shalloway, 1988). We found that purified MPF is indeed able to phosphorylate chicken c-src at the same sites in vitro as in vivo, producing an electrophoretic shift identical to the one observed during mitosis in vivo (Shenoy et a l. 1989) . Interestingly, the amino acid sequence around the phosphorylation sites has the same consensus sequence present in HI histone sites for MPF of (K /r )-S/t -P-(X ) A model sum m arizing this discussion is shown in F ig. 1 (Shenoy et al. 1989) . The model indicates that targets for M PF kinase exist both in the nucleus (HI) and the cytoplasm, including the plasma membrane (pp60v'src). T he phosphorylation of lamins required for nuclear envelope breakdown m ay be in part mediated by activation of S6 K II, which m ay be a result of M PF or PP60c'src-mediated mechanisms. Since a fraction of pp60c'src has been localized to the perinuclear region (Resh and Erikson, 1985) , it is possible nuclear c-src is also a substrate for M PF. These pathways provide working models for alteration of structural components by M PF in mitosis (HI, lam ins) as well as enzym atic components (pp60c'src and p42). A l l a n , J . , H a r t m a n , P . G ., C r a n e -R o b in so n , C . a n d A v il e s , F . X . (1 9 8 0 ) . T h e s tr u c tu r e of h isto n e H I a n d its lo c a tio n in c h ro m a tin . Nature, Lond. 288, 6 7 5 -6 7 9 . G a u t ie r , J., M in s h u l l , J., L o h k a , M . J., G l o t z e n , M ., H u n t , T . a n d M a l l e r , J. L . (1990).
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